Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2025-12-24 @ 4:04 PM
NCT ID: NCT00619866
Eligibility Criteria: Inclusion Criteria: * Be female, aged 18 to 49 years, inclusive * Have moderate to severe pelvic pain due to endometriosis * Have been surgically (laparoscopy) diagnosed with endometriosis within the last 8 years and have recurrent or persistent endometriosis symptoms * Have regular menstrual cycle * Have a body mass index (BMI) of 18 to 36 kg/m², inclusive * Agree to use two forms of non-hormonal contraception during the study Exclusion Criteria: * Are currently receiving gonadotropin-releasing hormone (GnRH) agonist or GnRH antagonist or have received any of these agents within 6 months of the start of screening * Are currently receiving subcutaneous medroxyprogesterone acetate (DMPA-SC) or intramuscular medroxyprogesterone acetate (DMPA-IM) or have received any of these agents within 3 months of the start of screening * Are currently using hormonal contraception or other forms of hormonal therapy or received such treatment within the last month * Have had surgery for endometriosis within the last month * Have had a hysterectomy or bilateral oophorectomy * Are using systemic steroids on a chronic or regular basis within 3 months * Have uterine fibroids ≥ 3 cm in diameter * Have pelvic pain that is not caused by endometriosis * Have unstable medical condition or chronic disease * Have been pregnant within the last six months * Currently breast feeding
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 49 Years
Study: NCT00619866
Study Brief:
Protocol Section: NCT00619866